Address:
1470 Madison Avenue, New York, NY 10029
Education:
Medical School - Albert Einstein College of Medicine (Degree: MD)
University of Virginia Health System (Residency - Internal Medicine)
University of Rochester School of Medicine & Dentistry (Fellowship - Hematology)
Awards and Publications:
Aledort L. Recombinant VIIa Is a Pan-hemostatic Agent?. Thromb Haemost 2000; 83: 637-638., Schwartz JD, Aledort L, Seremetis S. Liver failure and mortality in HIV positive hemophiliacs. Haemophilia 1997; 3: 24-30., Aledort L. Some Aspects on the Management of Hemophilia. Thromb Haemost 1995; 74(1): 440-443., Seremetis S. Principles of Managing Haemophiliac Bleeding. In: Forbes CD, Madhok R, Aledort L, editors. Textbook of Hemophilia. London, Chapman and Hall; 1997. pp165., Aledort L. Immune Tolerance Induction: Is it cost-effective? We know too little. Seminars in Thrombosis and Hemostasis 2000; 26(2): 189-193., Aledort L. Prophylaxis: for whom, when at what cost to patient and society?. Int Monitor on Hemophilia 1999; 7(2): 20-21., Pollman H, Aledort L. Albumin-Free Formulated Recombinant Factor VIII Preparations - How Big a Step Forward?. Thromb Haemost 1999; 82(4): 1370-1371., Alpha Therapeutic Award, Department of Medicine Service Award (Mount Sinai School of Medicine - 1984), proclaimed 'Lou Aledort Day' (Festschrift, presented by NHF - 1986), NHF Murray Thelin Science Award, Department of Nursing Life Time Achievement Award (Mount Sinai School of Medicine - 1990), Solomon Berson Award, Tribute Symposium: National, Cultural, and Economic Considerations Affecting Diagnostic and Treatment Practices in Hemophilia Thoughout the Americas: A Pan-Caribbean Conference (San Juan Puerto Rico - 1998)
Board certifications:
American Board of Internal Medicine, Hematology (Internal Medicine)
About:
Louis Aledort is a board-certified internist and hematologist who began his Mount Sinai career in 1966. A former Dean for Faculty and Hospital Affairs at Mount
Sinai School of Med...